In conclusion, this study represents the first comprehensive pan-cancer investigation of the TUBA1B oncogene, encompassing various omics analyses, prognostic assessments, epigenetic evaluations, methylation investigations, immune-related assays, and enrichment analyses. The gene discussed is TUBA1B; the disease is cancer.